Literature DB >> 24599985

Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Enterococci with low- and medium-level VanB-type vancomycin resistance: a multicenter study.

Kristin Hegstad1, Christian G Giske, Bjørg Haldorsen, Erika Matuschek, Kristian Schønning, Truls M Leegaard, Gunnar Kahlmeter, Arnfinn Sundsfjord.   

Abstract

Different antimicrobial susceptibility testing methods to detect low-level vancomycin resistance in enterococci were evaluated in a Scandinavian multicenter study (n=28). A phenotypically and genotypically well-characterized diverse collection of Enterococcus faecalis (n=12) and Enterococcus faecium (n=18) strains with and without nonsusceptibility to vancomycin was examined blindly in Danish (n=5), Norwegian (n=13), and Swedish (n=10) laboratories using the EUCAST disk diffusion method (n=28) and the CLSI agar screen (n=18) or the Vitek 2 system (bioMérieux) (n=5). The EUCAST disk diffusion method (very major error [VME] rate, 7.0%; sensitivity, 0.93; major error [ME] rate, 2.4%; specificity, 0.98) and CLSI agar screen (VME rate, 6.6%; sensitivity, 0.93; ME rate, 5.6%; specificity, 0.94) performed significantly better (P=0.02) than the Vitek 2 system (VME rate, 13%; sensitivity, 0.87; ME rate, 0%; specificity, 1). The performance of the EUCAST disk diffusion method was challenged by differences in vancomycin inhibition zone sizes as well as the experience of the personnel in interpreting fuzzy zone edges as an indication of vancomycin resistance. Laboratories using Oxoid agar (P<0.0001) or Merck Mueller-Hinton (MH) agar (P=0.027) for the disk diffusion assay performed significantly better than did laboratories using BBL MH II medium. Laboratories using Difco brain heart infusion (BHI) agar for the CLSI agar screen performed significantly better (P=0.017) than did those using Oxoid BHI agar. In conclusion, both the EUCAST disk diffusion and CLSI agar screening methods performed acceptably (sensitivity, 0.93; specificity, 0.94 to 0.98) in the detection of VanB-type vancomycin-resistant enterococci with low-level resistance. Importantly, use of the CLSI agar screen requires careful monitoring of the vancomycin concentration in the plates. Moreover, disk diffusion methodology requires that personnel be trained in interpreting zone edges.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599985      PMCID: PMC3993630          DOI: 10.1128/JCM.03544-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Nonconjugative transposition of the vanB-containing Tn5382-like element in Enterococcus faecium.

Authors:  Kristin H Dahl; Torunn P Røkenes; Eirik W Lundblad; Arnfinn Sundsfjord
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

2.  Clustering of polyclonal VanB-type vancomycin-resistant Enterococcus faecium in a low-endemic area was associated with CC17-genogroup strains harbouring transferable vanB2-Tn5382 and pRUM-like repA containing plasmids with axe-txe plasmid addiction systems.

Authors:  Eva Bjørkeng; Gunlög Rasmussen; Arnfinn Sundsfjord; Lennart Sjöberg; Kristin Hegstad; Bo Söderquist
Journal:  APMIS       Date:  2011-02-25       Impact factor: 3.205

3.  Draft genome sequence of the quality control strain Enterococcus faecalis ATCC 29212.

Authors:  Eun Bae Kim; Lauren M Kopit; Linda J Harris; Maria L Marco
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

4.  DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcus isolates.

Authors:  R Patel; J R Uhl; P Kohner; M K Hopkins; J M Steckelberg; B Kline; F R Cockerill
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 5.  Antibiotic resistant enterococci-tales of a drug resistance gene trafficker.

Authors:  Guido Werner; Teresa M Coque; Charles M A P Franz; Elisabeth Grohmann; Kristin Hegstad; Lars Jensen; Willem van Schaik; Keith Weaver
Journal:  Int J Med Microbiol       Date:  2013-03-08       Impact factor: 3.473

6.  Development of a standardized screening method for detection of vancomycin-resistant enterococci.

Authors:  J M Swenson; N C Clark; M J Ferraro; D F Sahm; G Doern; M A Pfaller; L B Reller; M P Weinstein; R J Zabransky; F C Tenover
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci.

Authors:  J M Swenson; N C Clark; D F Sahm; M J Ferraro; G Doern; J Hindler; J H Jorgensen; M A Pfaller; L B Reller; M P Weinstein
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

Review 8.  Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era.

Authors:  Michael S Gilmore; Francois Lebreton; Willem van Schaik
Journal:  Curr Opin Microbiol       Date:  2013-02-05       Impact factor: 7.934

9.  The vanG glycopeptide resistance operon from Enterococcus faecalis revisited.

Authors:  Florence Depardieu; Maria Grazia Bonora; Peter E Reynolds; Patrice Courvalin
Journal:  Mol Microbiol       Date:  2003-11       Impact factor: 3.501

10.  Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU.

Authors:  Guido Werner; Ingo Klare; Carola Fleige; Uta Geringer; Wolfgang Witte; Heinz-Michael Just; Renate Ziegler
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-30       Impact factor: 4.887

View more
  16 in total

1.  Low vancomycin MICs and fecal densities reduce the sensitivity of screening methods for vancomycin resistance in Enterococci.

Authors:  Thamara M Wijesuriya; Peta Perry; Todd Pryce; John Boehm; Ian Kay; James Flexman; Geoffrey W Coombs; Paul R Ingram
Journal:  J Clin Microbiol       Date:  2014-05-28       Impact factor: 5.948

2.  Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screening.

Authors:  K A Morris; L R Macfarlane-Smith; M H Wilcox
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-16       Impact factor: 3.267

3.  Evaluation of the Xpert vanA/vanB assay using enriched inoculated broths for direct detection of vanB vancomycin-resistant Enterococci.

Authors:  X Zhou; J P Arends; G A Kampinga; H M Ahmad; B Dijkhuizen; P van Barneveld; J W A Rossen; A W Friedrich
Journal:  J Clin Microbiol       Date:  2014-10-08       Impact factor: 5.948

Review 4.  Antimicrobial Susceptibility Testing for Enterococci.

Authors:  Ayesha Khan; William R Miller; Dierdre Axell-House; Jose M Munita; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2022-06-13       Impact factor: 11.677

Review 5.  Phenotypic and genotypic detection methods for antimicrobial resistance in ESKAPE pathogens (Review).

Authors:  Mădălina Maria Muntean; Andrei-Alexandru Muntean; Mădălina Preda; Loredana Sabina Cornelia Manolescu; Cerasella Dragomirescu; Mircea-Ioan Popa; Gabriela Loredana Popa
Journal:  Exp Ther Med       Date:  2022-06-09       Impact factor: 2.751

Review 6.  In vitro dissolution testing models of ocular implants for posterior segment drug delivery.

Authors:  Muhammad Faris Adrianto; Febri Annuryanti; Clive G Wilson; Ravi Sheshala; Raghu Raj Singh Thakur
Journal:  Drug Deliv Transl Res       Date:  2021-08-11       Impact factor: 5.671

7.  A multicentre hospital outbreak in Sweden caused by introduction of a vanB2 transposon into a stably maintained pRUM-plasmid in an Enterococcus faecium ST192 clone.

Authors:  Audun Sivertsen; Hanna Billström; Öjar Melefors; Barbro Olsson Liljequist; Karin Tegmark Wisell; Måns Ullberg; Volkan Özenci; Arnfinn Sundsfjord; Kristin Hegstad
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

8.  Prevalence of Virulence Factors and Vancomycin-resistant Genes among Enterococcus faecalis and E. faecium Isolated from Clinical Specimens.

Authors:  Mona Nasaj; Seyed Masoud Mousavi; Seyed Mostafa Hosseini; Mohammad Reza Arabestani
Journal:  Iran J Public Health       Date:  2016-06       Impact factor: 1.429

9.  A Silenced vanA Gene Cluster on a Transferable Plasmid Caused an Outbreak of Vancomycin-Variable Enterococci.

Authors:  Audun Sivertsen; Torunn Pedersen; Kjersti Wik Larssen; Kåre Bergh; Torunn Gresdal Rønning; Andreas Radtke; Kristin Hegstad
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

10.  Diagnostic Evasion of Highly-Resistant Microorganisms: A Critical Factor in Nosocomial Outbreaks.

Authors:  Xuewei Zhou; Alexander W Friedrich; Erik Bathoorn
Journal:  Front Microbiol       Date:  2017-11-03       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.